Skip to main content
OpenTrials
Completed

NCT Number: NCT03747874

OSA and Sudden Sensorineural Hearing Loss

This study studies the prevalence between obstructive sleep apnea syndrome and sensorineural hearing loss. We recruit patients who have been treated for sudden sensorineural hearing loss in Poitiers' University Hospital between 2010 et 2017, and we detect if they have OSA with a ventilatory polygraphy.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • past medical history of sudden hearing loss between 2010 and 2017
  • no contraindication to a non supervised sleeping monitoring

Exclusion criteria

  • past medical history of fluctuant hearing loss or pre-existant significative hearing loss

Treatment and study plan

ventilatory polygraphy

Diagnostic Test

we put a ventilatory polygraphy device on the patient in the evening, they come back home to sleep while the device is recording ventilatory parameters and they come back the morrow to give the device back

Primary outcomes

  1. Study of the prevalence of OSA on patient with a history of sudden hearing loss

    Time frame: 1 night

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Collaborators

  • ResMed

Registry information

Official study title

Prevalence of Obstructive Sleep Apnea Syndrome in Patients With a History of Sudden Sensorineural Hearing Loss

Acronym: SAS-SB

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Nov 20, 2018
Registry last updated
Jun 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.